Telemedically supported aftercare after living donor renal transplantation

Organizational Data

DRKS-ID:
DRKS00007634
Recruitment Status:
Recruiting complete, study complete
Date of registration in DRKS:
2015-01-28
Last update in DRKS:
2023-08-07
Registration type:
Retrospective

Acronym/abbreviation of the study

No Entry

URL of the study

http://www.transplantationszentrum-freiburg.de

Brief summary in lay language

The project study examines the effects of telemedically supported aftercare (telemedically supported case management) compared to the standard of aftercare for living donor renal transplant recipients. Expected outcomes are differences in number and length of stay of unplanned inpatient hospitalization, transplant function, adherence in regard to taking immunosuppressive drugs, health-related and disease-specific quality of life and the return to employment.

Brief summary in scientific language

A prospective, randomized, controlled and open project study with 46 living donor renal transplant recipients was initiated. • 23 patients with standard of care (as control group) • 23 patients with standard of care and telemedically supported aftercare (case management). Telemedical aspects: Touchscreen-Device with videocamera and microfone at home. Via an interactive web-based telemonitor, the telemedically supported aftercare group entered at home daily data about their physical condition into a defined medical questionnaire. These data were checked daily by medical staff of the Transplantation Center Freiburg. In case of noticeable entries a case management team member contacts the patient by mobile phone or video-conference to offer health-care related decision support and/or timely linking to direct medical services. Observation period: October 2011 to April 2014. Both groups have been examined at four time points (0, 3, 6 and 12 months after transplantation) via medical reports and standardized Interviews/Questionnaires (BAASIS®, ESRD-SCL®, BSI-18®, ALL) about the course of their medical condition (number and length of inpatient hospitalizations and the corresponding diagnoses, transplant function), their adherence concerning the intake of immunosuppressive medication, health-related and disease-specific quality of life and working time percentages.

Health condition or problem studied

ICD10:
N17-N19 - Renal failure
ICD10:
Z94.0 - Kidney transplant status
Healthy volunteers:
No Entry

Interventions, Observational Groups

Arm 1:
23 patients (Interventiongroup) with telemedically supported aftercare (case management) in the first year after renal transplantation additionally to standard of care. Daily data-entry in a defined questionnaire via remote monitoring. Remote monitoring and real-time video-conferences as a support for the patients in case of critical entries and when they are feeling insecure with daily life management.
Arm 2:
23 patients (standard of care group) with routine evidence-based aftercare in the first year after renal transplantation

Endpoints

Primary outcome:
Unplanned inpatient hospitalization (unplanned admission rate) at 3,6, 12 months after transplantation
Secondary outcome:
Unplanned prolonged inpatient hospitalization (length of unplanned stay), Rate of acute rejection, Sum of days until acute rejection therapy initiation, Maintenance of transplant function, Ambulatory care visits, Immunosuppressive regime adherence, Quality of life, Return to employment

Study Design

Purpose:
Supportive care
Allocation:
Randomized controlled study
Control:
  • Active control (effective treatment of control group)
Phase:
N/A
Study type:
Interventional
Mechanism of allocation concealment:
No Entry
Blinding:
No
Assignment:
Parallel
Sequence generation:
No Entry
Who is blinded:
No Entry

Recruitment

Recruitment Status:
Recruiting complete, study complete
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Germany
Number of study centers:
Monocenter study
Recruitment location(s):
  • University medical center Department Chirurgie, Klinik für Allgemein- und Visczeralchirurgie, Transplantationszentrum Freiburg im Breisgau

Recruitment period and number of participants

Planned study start date:
No Entry
Actual study start date:
2011-10-28
Planned study completion date:
No Entry
Actual Study Completion Date:
2014-04-30
Target Sample Size:
50
Final Sample Size:
46

Inclusion Criteria

Sex:
All
Minimum Age:
18 Years
Maximum Age:
no maximum age
Additional Inclusion Criteria:
Kidney transplantation in Tx Center Freiburg. Inclusion directly before discharge from hospital. Age >18. Ability to take medication independently. Literate German speaker. Consensus with randomization. Written consent in randomizad allocation and in anonymized data processing.

Exclusion Criteria

Age < 18. Challenged in taking medication independently. No literate German speaker. No consensus in randomized allocation and anonymized data processing.

Addresses

Primary Sponsor

Address:
Universitätsklinikum Freiburg, Department Chirurgie, Klinik für Allgemein- und Viszeralchirurgie,
Prof. Dr. Dr. h.c. Ulrich-Theodor Hopt
Hugstetter Strasse 55
79106 Freiburg
Germany
Telephone:
+49 761 270 28060
Fax:
+49 761 270 28040
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.uniklinik-freiburg.de
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
Universitätsklinikum Freiburg, Department Chirurgie,Klinik für Allgemein- und Viszeralchirurgie,Transplantationszentrum
PD Dr. Przemyslaw Pisarski
Hugstetter Strasse 55
79106 Freiburg
Germany
Telephone:
+49 761 270 28590
Fax:
+49 761 278970
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.transplantationszentrum-freiburg.de

Contact for Public Queries

Address:
Universitätsklinikum Freiburg, Department Chirurgie,Klinik für Allgemein- und Viszeralchirurgie,Transplantationszentrum
Dipl.-Psychol. Anja Schmid
Hugstetter Strasse 55
79106 Freiburg
Germany
Telephone:
+49 761 270 27320
Fax:
+49 761 278970
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.transplantationszentrum-freiburg.de

Principal Investigator

Address:
Universitätsklinikum Freiburg, Department Chirurgie,Klinik für Allgemein- und Viszeralchirurgie,Transplantationszentrum
PD Dr. Przemyslaw Pisarski
Hugstetter Strasse 55
79106 Freiburg
Germany
Telephone:
+49 761 270 28590
Fax:
+49 761 278970
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.transplantationszentrum-freiburg.de

Sources of Monetary or Material Support

Commercial (pharmaceutical industry, medical engineering industry, etc.)

Address:
Abteilung Transplantation & Immunologie
Roonstraße 25
90429 Nürnberg
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Public funding institutions financed by tax money/Government funding body (German Research Foundation (DFG), Federal Ministry of Education and Research (BMBF), etc.)

Address:
INTERREG IV Rhin Supérieur / OberrheinRégion Alsace – DREI
1 place Adrien Zeller – BP 91006
F 67070 STRASBOURG
France
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.interreg-oberrhein.eu/projet/prometheus-die-nikt-im-dienste-der-betreuung-von-transplantationspatienten/?cat=189-190

Institutional budget, no external funding (budget of sponsor/PI)

Address:
Universitätsklinikum Freiburg, Department Chirurgie,Klinik für Allgemein- und Viszeralchirurgie,Transplantationszentrum
Hugstetter Strasse 55
79106 Freiburg
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.transplantationszentrum-freiburg.de

Ethics Committee

Address Ethics Committee

Address:
Ethik-Kommission der Albert-Ludwigs-Universität Freiburg
Engelberger Str. 21
79106 Freiburg
Germany
Telephone:
+49-761-27072600
Fax:
+49-761-27072630
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2014-12-18
Ethics committee number:
608/14
Vote of the Ethics Committee:
Approved
Date of the vote:
2015-01-19

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
No
IPD Sharing Plan:
No Entry

Study protocol and other study documents

Study protocols:
No Entry
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry